Tony Hitchcock | 06/03/2015
Having worked in the development and production of early stage therapeutics for over 30 years I appreciate as much as anyone that this is often a highly challenging environment, not least with regards to overcoming technical and regulatory hurdles as well as seeking to meet a highly demanding timeline.
The development of new therapeutic entities is a complex and highly demanding enterprise to undertake; especially true for small biotech companies. Such projects are multi-faceted and include m...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
SmartLab Exchange Europe
February 25 - 26, 2025
Novotel Amsterdam City, Netherlands
Register Now |
View Agenda |
Learn More
SmartLab Exchange USA 2025
08 - 09 April, 2025
Le Méridien, Fort Lauderdale, Florida, USA
Register Now |
View Agenda |
Learn More